EverSource Wealth Advisors’s MBX Biosciences MBX Stock Holding History

EverSource Wealth Advisors’s Portfolio MBX Stock Details MBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.65K	Buy	48 +23	+92%	+$803	﹤0.01%	3603
2026 Q1	$746	Hold	25	–	–	﹤0.01%	3954
2025 Q4	$789	Buy	25 +2	+9%	+$49	﹤0.01%	3770
2025 Q3	$403	Sell	23 -6	-21%	-$80	﹤0.01%	4002
2025 Q2	$331	Buy	29 +20	+222%	+$204	﹤0.01%	3985
2025 Q1	$66	Buy	+9	New	+$95	﹤0.01%	3873

Other funds holding MBX

AWA

Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

KWM

Koa Wealth Management Encinitas, California $147M AUM 18.41% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

PWA

Physician Wealth Advisors Midvale, Utah $837M AUM 26% 1-Year Est. Return

EverSource Wealth Advisors's MBX Position: Q2 2026 in Review

EverSource Wealth Advisors increased its MBX Biosciences (MBX) stake by 92% in Q2 2026, buying an estimated $803 and bringing the position to 48 shares worth $2.65K. The position accounts for ﹤0.01% of the portfolio, ranked #3603.

EverSource Wealth Advisors first reported a position in MBX in Q1 2025 and has held it in 6 quarters since. 16 funds tracked by Wall St. Rank hold MBX as of Q2 2026.

EverSource Wealth Advisors held 48 shares of MBX Biosciences worth $2.65K as of Q2 2026.
EverSource Wealth Advisors bought 23 MBX Biosciences shares in Q2 2026, an estimated $803.
MBX Biosciences made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3603 holding.
EverSource Wealth Advisors first reported a position in MBX Biosciences in Q1 2025 and has held it in 6 quarters since.
16 funds tracked by Wall St. Rank held MBX Biosciences as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.